Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

Cardiologist-backed bill focused on the heart health of South Asian Americans gains momentum

After successfully making it through the House, the new legislation is now headed to the Senate. 

Thumbnail

Cardiologists, radiologists join American Medical Association to speak out against ACA lawsuit

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

Thumbnail

Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. 

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

Thumbnail

New guidelines detail PFO management, including when to consider closure

The new guidance document was designed to provide helpful information on a topic "surrounded by controversy." 

Kirk Garratt, past SCAI president, explains the impact of the iodine contrast shortage on interventional cardiology and the cath lab. #SCAI

VIDEO: How the iodine contrast shortage is impacting interventional cath labs

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.